News Dicot AB

Equities

End-of-day quote NORDIC GROWTH MARKET Other stock markets 03:30:00 03/05/2024 am IST			5-day change	1st Jan Change
0.268 ^SEK	+0.56%		+8.06%	-15.72%

23/04	Dicot AB Announces Positive Safety and Improved Efficacy Results from Phase 1 Study	CI
11/03	Dicot AB Announces Recruitment Completed in Dicot's Phase 1 Trial	CI

Good safety and improved erectile function reported from Dicot's phase 1 study	23/04	AQ
Dicot AB Announces Positive Safety and Improved Efficacy Results from Phase 1 Study	23/04	CI
Dicot in preparation for clinical phase 2a trial	12/04	AQ
Reporting from Dicot's phase 1 study end of April	05/04	AQ
BioStock: Dicot's phase I study fully recruited	14/03	AQ
Recruitment completed in Dicot's phase 1 trial	11/03	AQ
Dicot AB Announces Recruitment Completed in Dicot's Phase 1 Trial	11/03	CI
Dicot's CEO tells BioStock: "Several prominent people want to be part of the journey"	29/02	AQ
Dicot AB Year-End Report 2023	26/02	AQ
Dicot AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	26/02	CI
BioStock: Good safety profile for Dicot's LIB-01	26/01	AQ
Positive results from the first part of Dicot's phase 1 study	23/01	AQ
Dicot AB Presents Positive Results from the First Part of its Phase 1 Clinical Study	23/01	CI
Dicot Files New Manufacturing Technology Patent in Sweden; Stock Rises	11/01	MT
Dicot applies for patent covering new manufacturing technology	11/01	AQ
Dicot Applies for Patent Covering New Manufacturing Technology	11/01	CI
Dicot invited to present at ESSM for the third time	05/01	AQ
BioStock: Interim results from Dicot's phase I study to be released earlier than expected	20/12	AQ
Partial results from Dicot's phase 1 trial to be presented early next year	15/12	AQ
Dicot AB Announces Partial Results from Phase 1 Trial to Be Presented Early Next Year	15/12	CI

No results for this search